Zen, Kan <br/><br/>
Drug-eluting stenting for femoropopliteal lesions, followed by cilostazol treatment, reduces stent restenosis in patients with symptomatic peripheral artery disease.  [electronic resource] 

 -  Journal of vascular surgery  Mar 2017 
 - 720-725 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1097-6809 
<br/><br/><label>Standard No.: </label>10.1016/j.jvs.2016.10.098  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Cardiovascular Agents--administration & dosage<br/>Cilostazol<br/>Constriction, Pathologic<br/>Drug-Eluting Stents<br/>Endovascular Procedures--adverse effects<br/>Female<br/>Femoral Artery--diagnostic imaging<br/>Humans<br/>Japan<br/>Logistic Models<br/>Male<br/>Middle Aged<br/>Odds Ratio<br/>Paclitaxel--administration & dosage<br/>Peripheral Arterial Disease--complications<br/>Platelet Aggregation Inhibitors--administration & dosage<br/>Popliteal Artery--diagnostic imaging<br/>Propensity Score<br/>Prospective Studies<br/>Prosthesis Design<br/>Recurrence<br/>Registries<br/>Risk Factors<br/>Tetrazoles--administration & dosage<br/>Time Factors<br/>Treatment Outcome<br/>Ultrasonography, Doppler, Duplex<br/>Vascular Patency--drug effects